These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 22878964)
41. Genotype-Phenotype Correlation in Long-Term Cohort of Japanese Patients with Moyamoya Disease. Nomura S; Yamaguchi K; Akagawa H; Kawashima A; Moteki Y; Ishikawa T; Aihara Y; Saito T; Okada Y; Kawamata T Cerebrovasc Dis; 2019; 47(3-4):105-111. PubMed ID: 30947170 [TBL] [Abstract][Full Text] [Related]
42. RNF213 rare variants in an ethnically diverse population with Moyamoya disease. Cecchi AC; Guo D; Ren Z; Flynn K; Santos-Cortez RL; Leal SM; Wang GT; Regalado ES; Steinberg GK; Shendure J; Bamshad MJ; ; Grotta JC; Nickerson DA; Pannu H; Milewicz DM Stroke; 2014 Nov; 45(11):3200-7. PubMed ID: 25278557 [TBL] [Abstract][Full Text] [Related]
43. Early onset of moyamoya syndrome in a Down syndrome patient with the genetic variant RNF213 p.R4810K. Chong PF; Ogata R; Kobayashi H; Koizumi A; Kira R Brain Dev; 2015 Sep; 37(8):822-4. PubMed ID: 25547042 [TBL] [Abstract][Full Text] [Related]
44. In silico explanation for the causalities of deleterious RNF213 SNPs in Moyamoya disease and insulin resistance. Sarkar P; Thirumurugan K Comput Biol Chem; 2021 Jun; 92():107488. PubMed ID: 33930741 [TBL] [Abstract][Full Text] [Related]
45. The association between the ring finger protein 213 (RNF213) polymorphisms and moyamoya disease susceptibility: a meta-analysis based on case-control studies. Sun XS; Wen J; Li JX; Lai R; Wang YF; Liu HJ; Sheng WL Mol Genet Genomics; 2016 Jun; 291(3):1193-203. PubMed ID: 26847828 [TBL] [Abstract][Full Text] [Related]
47. Association of single nucleotide polymorphisms of MTHFR, TCN2, RNF213 with susceptibility to hypertension and blood pressure. Liu S; Liu M; Li Q; Liu X; Wang Y; Mambiya M; Zhang K; Yang L; Zhang Q; Shang M; Zeng F; Nie F; Liu W Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31815282 [TBL] [Abstract][Full Text] [Related]
48. Moyamoya Disease and Spectrums of RNF213 Vasculopathy. Bang OY; Chung JW; Kim DH; Won HH; Yeon JY; Ki CS; Shin HJ; Kim JS; Hong SC; Kim DK; Koizumi A Transl Stroke Res; 2020 Aug; 11(4):580-589. PubMed ID: 31650369 [TBL] [Abstract][Full Text] [Related]
49. Shin HS; Park GH; Choi ES; Park SY; Kim DS; Chang J; Hong JM J Cereb Blood Flow Metab; 2024 Oct; 44(10):1801-1815. PubMed ID: 38573771 [TBL] [Abstract][Full Text] [Related]
50. Association of Xue Y; Zeng C; Ge P; Liu C; Li J; Zhang Y; Zhang D; Zhang Q; Zhao J Stroke; 2022 Sep; 53(9):2906-2916. PubMed ID: 35543128 [TBL] [Abstract][Full Text] [Related]
51. Characterization of Moyamoya and Middle Cerebral Artery Diseases by Carotid Canal Diameter and RNF213 p.R4810K Genotype. Oichi Y; Mineharu Y; Agawa Y; Morimoto T; Funaki T; Hitomi T; Kobayashi H; Todo K; Tani S; Imamura H; Yoshida K; Kataoka H; Koizumi A; Sakai N; Miyamoto S J Stroke Cerebrovasc Dis; 2022 Jun; 31(6):106481. PubMed ID: 35430511 [TBL] [Abstract][Full Text] [Related]
52. Genetic Analysis of RNF213 c.14576G>A Variant in Nonatherosclerotic Quasi-Moyamoya Disease. Miyawaki S; Imai H; Shimizu M; Yagi S; Ono H; Nakatomi H; Shimizu T; Saito N J Stroke Cerebrovasc Dis; 2015 May; 24(5):1075-9. PubMed ID: 25817623 [TBL] [Abstract][Full Text] [Related]
53. Association of RNF213 polymorphism and cortical hyperintensity sign on fluid-attenuated inversion recovery images after revascularization surgery for moyamoya disease: possible involvement of intrinsic vascular vulnerability. Uchino H; Ito M; Tokairin K; Tatezawa R; Sugiyama T; Kazumata K; Fujimura M Neurosurg Rev; 2023 May; 46(1):119. PubMed ID: 37166684 [TBL] [Abstract][Full Text] [Related]
54. Prevalence of RNF213 variants in symptomatic intracranial arterial stenosis/occlusion in China. Sun X; Luo M; Li J; Lai R; Lin J; Wang Y; Xu X; Wu S; Sheng W Mol Genet Genomics; 2020 May; 295(3):635-643. PubMed ID: 32020275 [TBL] [Abstract][Full Text] [Related]
55. Posterior circulation involvement and collateral flow pattern in moyamoya disease with the RNF213 polymorphism. Kim WH; Kim SD; Nam MH; Jung JM; Jin SW; Ha SK; Lim DJ; Lee HB Childs Nerv Syst; 2019 Feb; 35(2):309-314. PubMed ID: 30283986 [TBL] [Abstract][Full Text] [Related]
56. Association between moyamoya syndrome and the RNF213 c.14576G>A variant in patients with neurofibromatosis Type 1. Phi JH; Choi JW; Seong MW; Kim T; Moon YJ; Lee J; Koh EJ; Ryu SK; Kang TH; Bang JS; Oh CW; Park SS; Lee JY; Wang KC; Kim SK J Neurosurg Pediatr; 2016 Jun; 17(6):717-22. PubMed ID: 26849809 [TBL] [Abstract][Full Text] [Related]
57. Rare RNF213 variant in adolescent with moyamoya disease. Cardoso I; Pinto M; Araújo A; Vila-Real M Rev Neurol; 2023 Mar; 76(5):177-181. PubMed ID: 36843178 [TBL] [Abstract][Full Text] [Related]
58. The association between the Moyamoya disease susceptible gene RNF213 variant and incident cardiovascular disease in a general population: the Nagahama study. Tabara Y; Yamada H; Setoh K; Matsukawa M; Takahashi M; Kawaguchi T; Nakayama T; Matsuda F; Kosugi S J Hypertens; 2021 Dec; 39(12):2521-2526. PubMed ID: 34738993 [TBL] [Abstract][Full Text] [Related]
59. Association of Ring Finger Protein 213 Gene P.R4810k Polymorphism with Intracranial Major Artery Stenosis/Occlusion. Zhang Q; Yu L; Ge P; Ma Y; Zhang D; Zhang Y; Wang R; Wang S; Zhao Y; Cao Y; Liu X; Deng X; Zhao J J Stroke Cerebrovasc Dis; 2018 Jun; 27(6):1556-1564. PubMed ID: 29482934 [TBL] [Abstract][Full Text] [Related]